Search results (11818)
« Back to PublicationsIdentification of circulating monocytes as producers of tuberculosis disease biomarker C1q
Journal article
Niewold P. et al, (2023), Scientific Reports, 13
Quantifying neutralising antibody responses against SARS-CoV-2 in dried blood spots (DBS) and paired sera
Journal article
Roper KJ. et al, (2023), Scientific Reports, 13
The collective voice of early phase COVID-19 vaccine trial participants: Insights for improving confidence in novel vaccines.
Journal article
Thomas TM. et al, (2023), Human vaccines & immunotherapeutics, 19, 2203023 - 2203023
Discordance between different bioinformatic methods for identifying resistance genes from short-read genomic data, with a focus on Escherichia coli
Journal article
Davies T. et al, (2023), Microbial Genomics
The metabolic, virulence and antimicrobial resistance profiles of colonising Streptococcus pneumoniae shift after PCV13 introduction in urban Malawi.
Journal article
Obolski U. et al, (2023), Nat Commun, 14
Deep learning and single-cell phenotyping for rapid antimicrobial susceptibility detection in Escherichia coli.
Journal article
Zagajewski A. et al, (2023), Commun Biol, 6
Salmonella Vaccine Study in Oxford (SALVO) trial: protocol for an observer-participant blind randomised placebo-controlled trial of the iNTS-GMMA vaccine within a European cohort.
Journal article
Hanumunthadu B. et al, (2023), BMJ Open, 13
Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors.
Journal article
Boby ML. et al, (2023), Science, 382
Chronic Hepatitis B Virus Infection and Risk of Stroke Types: A Prospective Cohort Study of 500 000 Chinese Adults.
Conference paper
Hamilton EM. et al, (2023), Stroke
Intravenous immunoglobulin treatment in childhood encephalitis (IgNiTE): a randomised controlled trial.
Journal article
Hill M. et al, (2023), BMJ Open, 13
Persistence of SARS-CoV-2 antibodies over 18 months following infection: UK Biobank COVID-19 Serology Study.
Journal article
Bešević J. et al, (2023), J Epidemiol Community Health
Probing long COVID through a proteomic lens: a comprehensive two-year longitudinal cohort study of hospitalised survivors.
Journal article
Gu X. et al, (2023), EBioMedicine, 98
A multi-platform approach to identify a blood-based host protein signature for distinguishing between bacterial and viral infections in febrile children (PERFORM): a multi-cohort machine learning study
Journal article
Jackson HR. et al, (2023), The Lancet. Digital health, 5, e774 - e785
HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV.
Journal article
Cargill T. et al, (2023), JHEP Rep, 5
Joint statement in support of hepatitis C human challenge studies.
Journal article
Alter HJ. et al, (2023), Lancet Gastroenterol Hepatol, 8, 967 - 969
Long COVID research: an update from the PHOSP-COVID Scientific Summit.
Journal article
Brightling CE. et al, (2023), Lancet Respir Med, 11, e93 - e94
Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study.
Journal article
C-MORE/PHOSP-COVID Collaborative Group None., (2023), Lancet Respir Med, 11, 1003 - 1019
The N6-methyladenosine demethylase ALKBH5 regulates the hypoxic HBV transcriptome.
Journal article
Tsukuda S. et al, (2023), bioRxiv
Respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination.
Journal article
Mitsi E. et al, (2023), Nat Commun, 14
Gonococcal PorB: a multifaceted modulator of host immune responses.
Journal article
Jones RA. et al, (2023), Trends Microbiol